Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342641 · ClinicalTrials.gov registry record
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 815,000
- Enrollment target
NCT00342641: Completed study, sponsored by National Cancer Institute (NCI).
NCT00342641 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 815,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00342641 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 815,000 participants
- Enrollment target
Study Summary
This study will investigate the possible relationship between infection with hepatitis C virus (HCV) and the development of certain hematologic cancers (Non-Hodgkin's lymphoma, Hodgkin's lymphoma, chronic lymphocytic leukemia, multiple myeloma) and thyroid cancer. HCV causes chronic hepatitis, cirrhosis, and liver cancer. It is transmitted primarily through injection drug use and transfusion of infected blood. Studies have shown that HCV may also be linked to hematologic cancers and thyroid cancer. This retrospective study will examine medical records from veterans with and without HCV infection who previously received treatment in the Veterans Administration medical system. Data collected on each subject will include the subject's race, sex, age and era of military service, presence of liver disease or thyroiditis at their baseline clinic visit, number of inpatient visits in the past 5 years and outpatient visits in the past year, and the presence of various specified cancers. The prevalence of cancer and other conditions among HCV-infected subjects and non-HCV infected subjects at baseline and the subsequent development of the cancers of interest in these two groups will be compared and analyzed for a possible causal relationship.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 815,000 participants |
| Start Date | 2005-06-08 |
| Est. Completion | 2011-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00342641
The ClinicalTrials.gov registry entry for NCT00342641 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 815,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00342641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00342641 about?
NCT00342641 is a clinical study titled "Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers". This study will investigate the possible relationship between infection with hepatitis C virus (HCV) and the development of certain hematologic cancers (Non-Hodgkin's lymphoma, Hodgkin's lymphoma, chronic lymphocytic leukemia, multiple myeloma) and thyroid cancer. HCV causes chronic hepatitis, cirrh...
What is the current status of trial NCT00342641?
This trial is currently completed. The enrollment target is 815,000 participants. The study started on 2005-06-08. Estimated completion is 2011-12-13.
Who is sponsoring clinical trial NCT00342641?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.